New Educational Initiative, Clinical Trials For All Launches
Noncommercial campaign seeks to drive more understanding, participation, and diversity.
A new noncommercial, educational campaign, Clinical Trials For All, is being launched to address the lack of awareness around clinical trials that is negatively impacting the health and welfare of people around the world.
“Clinical research isn’t what many people think it is,” said Cinda Orr, founder of SCORR Marketing in a press release. "Patient participation has continued to plague the clinical research industry for too long and research shows that a big reason for this is misunderstanding and awareness. Clinical Trials For All was designed to provide a full range of educational materials from dozens of patients, caregivers, patient advocates, health science organizations, and advocacy groups to help more understand the clinical trial process and how participation might be the right option for you or for a loved one.”
The
Another way to join in the cause is helping spread the word about clinical trials to friends, family, and future patients. The conversation can be joined by using #ClinicalTrialsForAll through
Patients, caregivers, patient advocates, health science organizations, and advocacy groups can join Clinical Trials For All as a partner. Current Platinum Partners include Virtue Research and MedVector, as well as a growing list of contributing and participating partners.
Reference
New Educational Initiative, Clinical Trials For All, to Drive More Understanding, Participation, and Diversity. (2023, August 22). Business Wire.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025